InsidersTradesSigma
Follow the 博济医药 stock price and the full insider trade history of the company, a publicly traded company based in China. Shares are quoted on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 博济医药 has recorded 5 reports. Market capitalisation: €3.6bn. The latest transaction was disclosed on 3 December 2025 (Sale). Among the most active insiders: 王廷春. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
5 of 5 declarations
博济医药是一家专注于医疗保健和制药领域的公司，在XSHE市场上市。该公司致力于创新药物的开发和商业化。